Israel Englander Enzo Biochem Inc Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Millennium Management LLC holds 32,386 shares of ENZ stock, worth $15,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,386

Previous 25,745 25.8%

Holding current value

$15,545

Previous $28,000 21.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.7 - $1.17 $4,648 - $7,769	6,641 Added 25.8%	32,386 $22,000
Q3 2024 Nov 14, 2024	BUY	$1.04 - $1.18 $6,637 - $7,530	6,382 Added 32.96%	25,745 $28,000
Q2 2024 Aug 14, 2024	BUY	$1.04 - $1.28 $20,137 - $24,784	19,363 New	19,363 $21,000
Q4 2023 Feb 14, 2024	BUY	$1.21 - $1.44 $30,623 - $36,444	25,309 New	25,309 $35,000
Q1 2023 May 15, 2023	BUY	$1.0 - $2.51 $70,685 - $177,419	70,685 New	70,685 $172,000
Q4 2021 Feb 14, 2022	SELL	$3.17 - $4.09 $126,502 - $163,215	-39,906 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.01 - $3.77 $1.13 Million - $1.41 Million	-374,776 Reduced 90.38%	39,906 $141,000
Q2 2021 Aug 16, 2021	BUY	$2.86 - $3.61 $906,448 - $1.14 Million	316,940 Added 324.26%	414,682 $1.32 Million
Q1 2021 May 17, 2021	BUY	$2.61 - $4.08 $135,550 - $211,894	51,935 Added 113.38%	97,742 $336,000
Q4 2020 Feb 16, 2021	BUY	$1.82 - $2.61 $83,368 - $119,556	45,807 New	45,807 $115,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.02 $318,867 - $476,722	-157,855 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.22 $63,462 - $96,390	29,935 Added 23.4%	157,855 $354,000
Q1 2020 May 14, 2020	BUY	$1.82 - $3.87 $163,190 - $347,003	89,665 Added 234.39%	127,920 $324,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $3.68 $98,315 - $140,778	38,255 New	38,255 $101,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.0 $266,282 - $353,864	-88,466 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.79 - $4.31 $220,156 - $340,097	78,909 Added 825.67%	88,466 $298,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $26,664 - $41,190	9,557 New	9,557 $697,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $128,503 - $219,395	-52,237 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.81 - $5.53 $362,197 - $525,709	-95,065 Reduced 64.54%	52,237 $215,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $1.91 Million - $2.56 Million	-378,189 Reduced 71.97%	147,302 $764,000
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $936,246 - $1.44 Million	172,421 Added 48.83%	525,491 $2.88 Million
Q4 2017 Feb 14, 2018	BUY	$8.15 - $10.55 $1.34 Million - $1.74 Million	164,871 Added 87.6%	353,070 $2.88 Million
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $1.97 Million - $2.15 Million	188,199	188,199 $1.97 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.7M

Call Options Held

2.3K

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $23.4M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account